Federally Recognized Tribes will get part of a $150 million settlement from opioid manufacturer Hikma Pharmaceuticals for its part in the nationwide opioid crisis. The settlement includes $115 million cash and $35 million worth of opioid overdose reversal drugs. It will be distributed among state, local and Tribal governments over the next 18 years.